Literature DB >> 9717954

Tamoxifen in early breast cancer.

T Saibara, Y Ogawa, S Onishi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717954     DOI: 10.1016/S0140-6736(05)60502-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.

Authors:  Rosa Anna DeFilippis; Hang Chang; Nancy Dumont; Joseph T Rabban; Yunn-Yi Chen; Gerald V Fontenay; Hal K Berman; Mona L Gauthier; Jianxin Zhao; Donglei Hu; James J Marx; Judy A Tjoe; Elad Ziv; Maria Febbraio; Karla Kerlikowske; Bahram Parvin; Thea D Tlsty
Journal:  Cancer Discov       Date:  2012-07-09       Impact factor: 39.397

2.  Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.

Authors:  Craig J Galbán; Bing Ma; Dariya Malyarenko; Martin D Pickles; Kevin Heist; Norah L Henry; Anne F Schott; Colleen H Neal; Nola M Hylton; Alnawaz Rehemtulla; Timothy D Johnson; Charles R Meyer; Thomas L Chenevert; Lindsay W Turnbull; Brian D Ross
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 3.  Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.

Authors:  Michael S Shawky; Hilary Martin; Honor J Hugo; Thomas Lloyd; Kara L Britt; Andrew Redfern; Erik W Thompson
Journal:  Oncotarget       Date:  2017-01-17

4.  The effect of antineoplastic drugs in a male spontaneous mammary tumor model.

Authors:  Stephanie N Shishido; Emma B Faulkner; Amanda Beck; Thu A Nguyen
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.